Yuva Bio secures $7.5M for topical skin and hair treatment targeting mitochondrial dysfunction
Longevity Technology - 26-Feb-2024Its Y100 technology combats hair loss and potentially other age-related issues
Join the club for FREE to access the whole archive and other member benefits.
Co-founder & CEO at Nantero and Chairman of Yuva Biosciences
Greg Schmergel is a serial entrepreneur, Co-founder & CEO at Nantero and Chairman of Yuva Biosciences. He serves as Board member of the Lahey Hospital & Medical Center and of the Lahey Clinic Foundation and as a Venture Partner at Rubicon Venture Capital. Previosuly, he worked as Senior Vice President for About, and CEO of ExpertCentral.com. He holds an AB magna cum laude from Harvard University and an MBA from the Harvard Graduate School of Business Administration.
Visit website: https://yuvabio.com/boardof.php
See also: Yuva Biosciences - Anti-aging startup company based in US
Details last updated 09-Apr-2021
Its Y100 technology combats hair loss and potentially other age-related issues
Targets mitochondrial dysfunction - cosmeceuticals on its way to reverse ageing signs in humans